Press Releases
Press Releases
Lilly to boost diabetes drug production with $450M factory investment
Eli Lilly and Co. plans to build a new $2.5 billion high-tech manufacturing site in Alzey, Rhineland-Palatinate, Germany to expand its global parenteral product and device manufacturing network and support increased demand for its diabetes and obesity portfolio.
With the...
Press Releases
CPHI & PMEC India Expo Returns with Renewed Vision for the Pharmaceutical Landscape
Marking the 16th year of unparalleled success, the CPHI & PMEC India Expo, orchestrated by Informa Markets in India, India's preeminent B2B event organizer, is gearing up for a triumphant return. As the largest and most exhaustive pharmaceutical industry...
Drug Research
Greenphire and Florence Healthcare Announce Technology Partnership
Greenphire, the global leader in patient convenience and financial lifecycle management for clinical trials, and Florence Healthcare, the leading site enablement platform used by 18,000 connected research sites in 55 countries, announce a technology partnership that integrates two of...
IT & Data Management
Pistoia Alliance Sets Out Strategic Priorities to Accelerate Sustainability, Adoption of AI, and use of FAIR and Real-World Data in R&D
The Pistoia Alliance, a global, not-for-profit alliance that advocates for greater collaboration in life sciences R&D, has announced its four new strategic priorities, and has appointed steering committees to lead collaboration in these areas: Harness AI to Expedite R&D,...
Packaging & Labelling
Tower Cold Chain announces the Evolution of the pharmaceutical cold chain
The latest innovation from Tower Cold Chain, a pioneer in passive temperature-controlled containers, offers pharmaceutical manufacturers, airlines and 3PL providers a single solution compatible with U.S. and E.U. pallets – with an ultra-lightweight design.
The Evolution 1600 Tower Universal Pallet,...
Drug Research
Charles River and Aitia Enter Strategic Agreement to Utilize Logica in Discovery Programs for Neurodegenerative Diseases and Oncology
Charles River Laboratories International, Inc. and Aitia, a leader in the application of Causal AI and Digital Twins announced a strategic agreement that gives Aitia access to Logica™, Charles River's Artificial Intelligence (AI) powered drug solution platform, for the...
Drug Research
Novartis Enters into Deal with Legend Biotech for $100 Million Upfront
Legend Biotech has secured an exclusive global license deal with Novartis giving the Swiss pharma access to Legend’s CAR-T cell therapies.
The deal will give Novartis access to CAR-Ts that target the delta-like ligand protein (DLL3) candidate LB2102, which Legend...
Subscribe
- Never miss a story with notifications
- Gain full access to our premium content
- Browse free from any location or device.